FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: opalapril who wrote (21)	10/6/1999 5:37:00 PM
From: Edscharp	Read Replies (1) of 75

Opal, You said, "MLNM is too expensive for my taste rights now" How does one objectively determine this? Part of my point in my previous post on Millenium is that they are a special case. Millenium is currently losing money so you can't figure price based on profit. What they have is a huge and growing proprietary interest in drug discoveries, databases, alliances and technology to make it all but certain that somewhere down the road they will be a successful company. Even if only a small percent of the potential drugs they've uncovered come to market they will do well. It's difficult to determine which of the genomic companies will dominate the Pharmaceutical Industry a decade from now. What is certain is that Millenium will be one of the players. The genomic companies of today will be providing the infrastructure for 90% of the drug discoveries a decade from now. You want mitigated risk? Sell all your other biotechs and buy this one.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next